AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21942655
Drug: DHEA 10
RxNorm normalized name: calcium carbonate 118 MG (calcium 47 MG) / DHEA 10 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA 10 mg daily
Trial: 21942655
Drug: HRT (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT (1 mg estradiol + 5 mg dihydrogesterone)
Trial: 11295026
Drug: Preparation A
RxNorm normalized name: POVIDONE-IODINE 75 mg in 1 mL TOPICAL SOLUTION [Antiseptic Patient Preoperative Skin Preparation and Surgical Hand Scrub]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation A (800 microg folic acid, 6 microg vitamin B12, 10 mg vitamin B6)
Trial: 11295026
Drug: Preparation B
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation B (160 microg folic acid, no vitamin B12, 10 mg vitamin B6)
Trial: 9399608
Drug: Diltiazem CD
RxNorm normalized name: Diltiazem Hydrochloride 300 MG Oral Capsule, Extended Release, 24 HR [DILTIAZEM CD]
DrugBank: Diltiazem (DB00343)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diltiazem CD 246 mg
Trial: 7703633
Drug: TCM-WM therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCM-WM therapy
Trial: 25636669
Drug: Bilateral injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral injection of technetium-99m macroaggregated albumin (37 MBq/1 mCi per injection)
Trial: 25636669
Drug: Unilateral injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unilateral injection of technetium-99m macroaggregated albumin (37 MBq/1 mCi per injection)
Trial: 19900212
Drug: Non-prostaglandin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-prostaglandin therapy (non-PGs)
Trial: 19900212
Drug: Latanoprost and
RxNorm normalized name: latanoprost and netarsudil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Latanoprost and Non-prostaglandin therapy (non-PGs)
Trial: 15019894
Drug: Pravastatin 40
RxNorm normalized name: pravastatin 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 40 mg once daily for 3 weeks before and 6 weeks after electrical cardioversion
Trial: 15019894
Drug: No drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drug in addition to standard therapy
Trial: 8221559
Drug: Cisplatin-epidoxorubicin-cyclophosphamide (CEP)
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin-epidoxorubicin-cyclophosphamide (CEP) chemotherapy alone
Trial: 24749354
Drug: Domestically produced
RxNorm normalized name: domestic cow dander extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domestically produced Salbutamol Sulfate Aerosol MDI (200 microg single-dose)
Trial: 24749354
Drug: Imported Salbutamol
RxNorm normalized name: black imported fire ant allergenic extract
DrugBank: Solenopsis richteri (DB11026)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imported Salbutamol Sulfate Aerosol MDI (200 microg single-dose)
Trial: 15966702
Drug: Buccal bioadhesive
RxNorm normalized name: urea
DrugBank: Urea (DB03904)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal bioadhesive nystatin tablet (100,000 IU per tablet) applied daily
Trial: 15966702
Drug: Conventional local
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional local cleaning with oral nystatin suspension on a brush
Trial: 15966702
Drug: No antimicrobial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antimicrobial agents (Control group)
Trial: 9445494
Drug: Stavudine (d4T)
RxNorm normalized name: STAVUDINE (d4T)
DrugBank: Stavudine (DB00649)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stavudine (d4T) 1 mg/kg orally every 12 hours, maximum 40 mg orally every 12 hours
Trial: 9445494
Drug: Zidovudine (ZDV,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidovudine (ZDV, AZT) 180 mg/m2 orally every 6 hours, maximum 200 mg orally every 6 hours
Trial: 7599909
Drug: Dipyrone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyrone (1 g, 3 times/day for 2 days, followed by twice 1 g on day 3)
Trial: 7599909
Drug: Diclofenac (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (50 mg, 3 times/day for 2 days, followed by twice 50 mg on day 3)
Trial: 2369315
Drug: Fluorouracil therapy
RxNorm normalized name: Fluorouracil
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluorouracil therapy (500 mg/m2 per day) by portal vein infusion for 7 days
Trial: 2369315
Drug: Fluorouracil therapy
RxNorm normalized name: Fluorouracil
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluorouracil therapy
Trial: 327057
Drug: Combined doses
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined doses of Fenfluramine and Dextroamphetamine
Trial: 31895437
Drug: Sertraline hydrochloride
RxNorm normalized name: sertraline hydrochloride
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sertraline hydrochloride for 8 weeks
Trial: 28126706
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Sertraline and Placebo)
Trial: 31511044
Drug: Leucine-enriched essential
RxNorm normalized name: Leucine
DrugBank: Leucine (DB00149)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Leucine-enriched essential amino acid (L-EAA) supplementation (5 g L-EAA five times per day for up to 14 days)
Trial: 28045286
Drug: panic‐focused psychodynamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: panic‐focused psychodynamic psychotherapy, cognitive‐behavioral therapy, or applied relaxation therapy (24 twice‐weekly sessions)
Trial: 21266669
Drug: Insulin immunodepletion
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin immunodepletion
Trial: 19860922
Drug: Phase 2
RxNorm normalized name: Premphase 28 Day Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phase 2 white bean extract (powder) at 3000 mg
Trial: 19860922
Drug: Phase 2
RxNorm normalized name: Premphase 28 Day Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phase 2 white bean extract (capsule) at 2000 mg
Trial: 19860922
Drug: Phase 2
RxNorm normalized name: Premphase 28 Day Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phase 2 white bean extract (capsule) at 3000 mg
Trial: 19860922
Drug: Phase 2
RxNorm normalized name: Premphase 28 Day Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phase 2 white bean extract (powder) at 1500 mg
Trial: 19860922
Drug: Phase 2
RxNorm normalized name: Premphase 28 Day Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phase 2 white bean extract (powder) at 2000 mg
Trial: 15217941
Drug: S-1 with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1 with food (35 mg/m2)
Trial: 15217941
Drug: S-1 without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-1 without food (35 mg/m2)
Trial: 11209118
Drug: Itraconazole (pulse)
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole (pulse) 200 mg twice a day for 1 week, given for 3 pulses
Trial: 8067598
Drug: 200 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 micrograms of fluticasone propionate once daily
Trial: 8067598
Drug: 100 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 micrograms of fluticasone propionate twice daily
Trial: 2897912
Drug: Pancuronium (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancuronium (single bolus 0.95 mg kg‐1)
Trial: 2897912
Drug: Atracurium (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium (single bolus 0.53 mg kg‐1)
Trial: 2897912
Drug: Vecuronium (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium (single bolus 0.07 mg kg‐1)
Trial: 2897912
Drug: Pancuronium (divided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancuronium (divided doses 0.15 mg kg‐1, 3 min before 0.08 mg kg‐1)
Trial: 2897912
Drug: Atracurium (divided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium (divided doses 0.07 mg kg‐1, 3 min before 0.46 mg kg‐1)
Trial: 2897912
Drug: Vecuronium (divided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium (divided doses 0.01 mg kg‐1, 3 min before 0.06 mg kg‐1)
Trial: 1093330
Drug: Sch 1000
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sch 1000 (Atrovent) 0.02 mg
Trial: 1093330
Drug: Sch 1000
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sch 1000 (Atrovent) 0.08 mg
Trial: 26109589
Drug: apixaban (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: apixaban (5 mg twice daily)
Trial: 23886150
Drug: CIK cell
RxNorm normalized name: Testone CIK KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIK cell therapy (5 courses over 18 months)
Trial: 23886150
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no CIK cell therapy)
Trial: 22779193
Drug: Naoxintong capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naoxintong capsule
Trial: 22779193
Drug: Tongxinluo capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tongxinluo capsule (Control)
Trial: 11380463
Drug: Sequential ADE
RxNorm normalized name: Stahist AD
DrugBank: Chlorcyclizine (DB08936)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential ADE (cytarabine, daunorubicin, etoposide)
Trial: 11380463
Drug: Sequential ADE
RxNorm normalized name: Stahist AD
DrugBank: Chlorcyclizine (DB08936)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential ADE
Trial: 8536027
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg pethidine (i. art.) in 50 ml saline
Trial: 8536027
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg pethidine + 200 micrograms adrenaline (i. art.) in 50 ml saline
Trial: 8536027
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg prilocaine + 200 micrograms adrenaline (i. art.) in a volume of 50 ml
Trial: 3691607
Drug: Acute AMI
RxNorm normalized name: ephedrine sulfate / hydroxyzine hydrochloride / theophylline Oral Tablet [Ami-rax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute AMI 50 mg
Trial: 27272084
Drug: Face cream
RxNorm normalized name: NAIR FACE CREAM,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Face cream containing 4-Hexyl-1, 3-phenylenediol and ascorbic acid-2 glucoside
Trial: 16160867
Drug: NPH insulin
RxNorm normalized name: NPH Insulin, Human 300 UNT per 3 ML Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NPH insulin (0.4 IU/kg)
Trial: 16160867
Drug: Insulin ultralente
RxNorm normalized name: INSULIN ULTRALENTE BEEF 100 U/ML IJ NOVO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin ultralente (0.4 IU/kg)
Trial: 14615229
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of different analysis methods
Trial: 26245776
Drug: Clobazam (medium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobazam (medium and high dosage)
Trial: 26245776
Drug: Clobazam (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobazam (low dosage)
Trial: 23384975
Drug: Compounded estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compounded estrogen cream (Bi‐est (80:20); 2.0 mg) + compounded oral progesterone 100 mg
Trial: 23384975
Drug: Compounded estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compounded estrogen cream (Bi‐est (80:20); 2.5 mg) + compounded oral progesterone 100 mg
Trial: 23384975
Drug: Compounded estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compounded estrogen cream (Bi‐est (80:20); 3.0 mg) + compounded oral progesterone 100 mg
Trial: 21279864
Drug: Caffeine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (3 mg · kg(‐1) body weight) after a 4-day withdrawal period
Trial: 21279864
Drug: Caffeine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (3 mg · kg(‐1) body weight) without a withdrawal period
Trial: 15621120
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) 1000 mg twice a day with stepwise reduction of CNI
Trial: 15621120
Drug: Continue current
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continue current CNI dose
Trial: 11273951
Drug: Ketorolac 30
RxNorm normalized name: ketorolac 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 30 mg IM (Group K)
Trial: 9678092
Drug: Low‐dose, gestodene‐containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low‐dose, gestodene‐containing triphasic oral contraceptive
Trial: 8388583
Drug: Enoxaparin (EN)
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (EN) 40 mg
Trial: 8388583
Drug: Enoxaparin (EN)
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (EN) 1 mg kg‐1
Trial: 8388583
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UH) 5,000 IU
Trial: 28624553
Drug: Tamsulosin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.2 mg daily for 8 weeks
Trial: 28624553
Drug: Naftopidil 75
RxNorm normalized name: Naftopidil
DrugBank: Naftopidil (DB12092)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Naftopidil 75 mg daily for 8 weeks
Trial: 22516884
Drug: Horticultural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Horticultural therapy (n = 37)
Trial: 22516884
Drug: Pain-management program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pain-management program without horticultural therapy (control, n = 42)
Trial: 8659720
Drug: Droperidol 2.5
RxNorm normalized name: droperidol 2.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 2.5 mg with induction of anesthesia and 1.25 mg 12 h later (Group 2, n = 25)
Trial: 8659720
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg with induction (Group 3, n = 25)
Trial: 8659720
Drug: Ondansetron plus
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ondansetron plus droperidol at the same doses as Groups 3 and 2 (Group 4, n = 25)
Trial: 29292694
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg multiunit pellet system (MUPS) tablets
Trial: 29292694
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg banded capsules
Trial: 22297597
Drug: Nonsurgical periodontal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nonsurgical periodontal therapy (NSPT)
Trial: 24965218
Drug: Nonsurgical periodontal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nonsurgical periodontal therapy (NSPT) and Oral hygiene instructions (OHI)
Trial: 17701044
Drug: Transurethral ultrasonography-guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transurethral ultrasonography-guided injections of autologous myoblasts and fibroblasts
Trial: 17701044
Drug: Transurethral endoscopic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transurethral endoscopic injections of collagen
Trial: 11893435
Drug: Maternal supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal supplementation of antioxidant vitamins (beta-carotene 20 mg, vitamin E 167.8 mg, vitamin C 1000 mg daily until delivery)
Trial: 9451067
Drug: High flow
RxNorm normalized name: Blood Set High Flow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High flow rate (200 ml/min)
Trial: 9451067
Drug: Low flow
RxNorm normalized name: high mallow flower extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low flow rate (100 ml/min)
Trial: 8560537
Drug: Oral 'conventional'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 'conventional' regimen (combination of chloramphenicol, cotrimoxazole, and doxycycline)
Trial: 31345778
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg norursodeoxycholic acid
Trial: 31345778
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg norursodeoxycholic acid
Trial: 29896930
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid infusion (L‐[2,3,3,4,5,5,5,6,6,6‐2 H10 ]leucine at 0.15 μmol/kg fat‐free mass/min)
Trial: 21028969
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (20 mg of elemental zinc daily for 8 weeks)
Trial: 12008859
Drug: Anakinra 30
RxNorm normalized name: ANAKINRA
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Anakinra 30 to 150 mg subcutaneously each day for 24 weeks
Trial: 12008859
Drug: Infliximab 3
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab 3 to 10 mg/kg intravenously every 4 or 8 weeks
Trial: 28536308
Drug: Melanoma peptide
RxNorm normalized name: peptide-T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melanoma peptide vaccine
Trial: 28536308
Drug: GM-CSF and/or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM-CSF and/or peptide vaccine
Trial: 23452375
Drug: Hydroxychloroquine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine (200 to 400 mg daily for 12 months)
Trial: 17149552
Drug: Lactulose 30
RxNorm normalized name: Lactulose
DrugBank: Lactulose (DB00581)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lactulose 30 ml orally 48 and 24 h prior to sigmoidoscopy, plus a single Fleet enema 2 h pre-procedure (Group 3)
Trial: 8917241
Drug: Pseudoephedrine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pseudoephedrine (30 or 60 mg)
Trial: 8917241
Drug: Phenylpropanolamine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylpropanolamine (20 or 37.5 mg)
Trial: 18798083
Drug: Caffeine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (300 mg oral administration)
Trial: 15115973
Drug: UDCA (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA (4 mg/kg per day)
Trial: 8611058
Drug: Coping skills
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coping skills therapy (with placebo)
Trial: 8611058
Drug: Supportive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive therapy (with placebo)
Trial: 6347750
Drug: 3-day clotrimazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-day clotrimazole treatment (200 mg once a day for 3 consecutive days)
Trial: 6347750
Drug: 6-day clotrimazole
RxNorm normalized name: Clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 6-day clotrimazole treatment (100 mg once a day for 6 consecutive days)
Trial: 29735467
Drug: Small dose
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small dose mifepristone
Trial: 26432913
Drug: 50μg gE/AS01B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50μg gE/AS01B formulation (HZ/su)
Trial: 22898028
Drug: Domperidone gel
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone gel (1.1 mg/kg, PO, once daily)
Trial: 22898028
Drug: Domperidone gel
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone gel
Trial: 20714379
Drug: Farcosolvin syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Farcosolvin syrup (ambroxol 15 mg, theophylline 50 mg, guaiphenesin 30 mg per 5 mL)
Trial: 20714379
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (guaiphenesin treatment)
Trial: 17975955
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no laser treatment) with AH Plus cement
Trial: 17975955
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no laser treatment) with EndoREZ cement
Trial: 17314442
Drug: 5% topical
RxNorm normalized name: BP 5% Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% topical tea tree oil gel
Trial: 15036669
Drug: Flutamide 750mg
RxNorm normalized name: Flutamide
DrugBank: Flutamide (DB00499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flutamide 750mg daily
Trial: 29991347
Drug: Continue sertraline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continue sertraline
Trial: 26914134
Drug: Methoxamine 2
RxNorm normalized name: methoxamine 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methoxamine 2 mg alone (Group M)
Trial: 26914134
Drug: Methoxamine 2
RxNorm normalized name: methoxamine 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methoxamine 2 mg with atropine 0.1 mg (Group MA1)
Trial: 26914134
Drug: Methoxamine 2
RxNorm normalized name: methoxamine 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methoxamine 2 mg with atropine 0.2 mg (Group MA2)